Article
Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia.
Blood cancer journal - 9 Jan 2020
Xu Lu-Hong, Fang Jian-Pei, Liu Yao-Chung, Jones Adrianna I, Chai Li
Abstract excerpt
Studies on the clinical significance of Nucleophosmin (NPM1) mutations in pediatric AML in a large cohort are lacking. Moreover, the prognosis of patients with co-occurring NPM1 and FLT3/ITD mutations is controversial. Here, we analyzed the impact of NPM1 mutations on prognoses of 869 pediatric AML patients from the TAGET dataset. The frequency of NPM1 mutations was 7.6%. NPM1 mutations were significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
